BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18400841)

  • 1. Metabolic correlates of subthalamic nucleus activity in Parkinson's disease.
    Lin TP; Carbon M; Tang C; Mogilner AY; Sterio D; Beric A; Dhawan V; Eidelberg D
    Brain; 2008 May; 131(Pt 5):1373-80. PubMed ID: 18400841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network modulation in the treatment of Parkinson's disease.
    Asanuma K; Tang C; Ma Y; Dhawan V; Mattis P; Edwards C; Kaplitt MG; Feigin A; Eidelberg D
    Brain; 2006 Oct; 129(Pt 10):2667-78. PubMed ID: 16844713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontal FDG-PET activity correlates with cognitive outcome after STN-DBS in Parkinson disease.
    Kalbe E; Voges J; Weber T; Haarer M; Baudrexel S; Klein JC; Kessler J; Sturm V; Heiss WD; Hilker R
    Neurology; 2009 Jan; 72(1):42-9. PubMed ID: 19122029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dorsolateral subthalamic neuronal activity enhanced by median nerve stimulation characterizes Parkinson's disease during deep brain stimulation with general anesthesia.
    Tsai ST; Chuang WY; Kuo CC; Chao PC; Chen TY; Hung HY; Chen SY
    J Neurosurg; 2015 Dec; 123(6):1394-400. PubMed ID: 26024004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resting-state functional magnetic resonance imaging of the subthalamic microlesion and stimulation effects in Parkinson's disease: Indications of a principal role of the brainstem.
    Holiga Š; Mueller K; Möller HE; Urgošík D; Růžička E; Schroeter ML; Jech R
    Neuroimage Clin; 2015; 9():264-74. PubMed ID: 26509113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective network of deep brain stimulation of subthalamic nucleus with bimodal positron emission tomography/functional magnetic resonance imaging in Parkinson's disease.
    Chen HM; Sha ZQ; Ma HZ; He Y; Feng T
    CNS Neurosci Ther; 2018 Feb; 24(2):135-143. PubMed ID: 29222835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified Fluorodeoxyglucose Metabolism in Motor Circuitry by Subthalamic Deep Brain Stimulation.
    Cao C; Zhang H; Li D; Zhan S; Zhang J; Zhang X; Zuo C; Sun B
    Stereotact Funct Neurosurg; 2017; 95(2):93-101. PubMed ID: 28259880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved sensory gating of urinary bladder afferents in Parkinson's disease following subthalamic stimulation.
    Herzog J; Weiss PH; Assmus A; Wefer B; Seif C; Braun PM; Pinsker MO; Herzog H; Volkmann J; Deuschl G; Fink GR
    Brain; 2008 Jan; 131(Pt 1):132-45. PubMed ID: 17977862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency-correlated decreases of motor cortex activity associated with subthalamic nucleus stimulation in Parkinson's disease.
    Haslinger B; Kalteis K; Boecker H; Alesch F; Ceballos-Baumann AO
    Neuroimage; 2005 Nov; 28(3):598-606. PubMed ID: 16081302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease.
    Trost M; Su S; Su P; Yen RF; Tseng HM; Barnes A; Ma Y; Eidelberg D
    Neuroimage; 2006 May; 31(1):301-7. PubMed ID: 16466936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in regional cerebral blood flow caused by deep-brain stimulation of the subthalamic nucleus in Parkinson's disease.
    Sestini S; Scotto di Luzio A; Ammannati F; De Cristofaro MT; Passeri A; Martini S; Pupi A
    J Nucl Med; 2002 Jun; 43(6):725-32. PubMed ID: 12050315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson's disease.
    Hilker R; Voges J; Weisenbach S; Kalbe E; Burghaus L; Ghaemi M; Lehrke R; Koulousakis A; Herholz K; Sturm V; Heiss WD
    J Cereb Blood Flow Metab; 2004 Jan; 24(1):7-16. PubMed ID: 14688612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain networks underlying the clinical effects of long-term subthalamic stimulation for Parkinson's disease: a 4-year follow-up study with rCBF SPECT.
    Sestini S; Ramat S; Formiconi AR; Ammannati F; Sorbi S; Pupi A
    J Nucl Med; 2005 Sep; 46(9):1444-54. PubMed ID: 16157526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of STN DBS on vesicular monoamine transporter 2 and glucose metabolism in Parkinson's disease.
    Smith GS; Mills KA; Pontone GM; Anderson WS; Perepezko KM; Brasic J; Zhou Y; Brandt J; Butson CR; Holt DP; Mathews WB; Dannals RF; Wong DF; Mari Z
    Parkinsonism Relat Disord; 2019 Jul; 64():235-241. PubMed ID: 31053531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of fluctuating striatal synaptic dopamine levels in patients with Parkinson disease in response to subthalamic nucleus stimulation: a positron emission tomography study.
    Nimura T; Yamaguchi K; Ando T; Shibuya S; Oikawa T; Nakagawa A; Shirane R; Itoh M; Tominaga T
    J Neurosurg; 2005 Dec; 103(6):968-73. PubMed ID: 16381182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of bilateral subthalamic nucleus stimulation on resting-state cerebral glucose metabolism in advanced Parkinson's disease.
    Zhao YB; Sun BM; Li DY; Wang QS
    Chin Med J (Engl); 2004 Sep; 117(9):1304-8. PubMed ID: 15377418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STN-DBS activates the target area in Parkinson disease: an FDG-PET study.
    Hilker R; Voges J; Weber T; Kracht LW; Roggendorf J; Baudrexel S; Hoevels M; Sturm V; Heiss WD
    Neurology; 2008 Sep; 71(10):708-13. PubMed ID: 18650492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SPECT and PET analysis of subthalamic stimulation in Parkinson's disease: analysis using a manual segmentation.
    Haegelen C; García-Lorenzo D; Le Jeune F; Péron J; Gibaud B; Riffaud L; Brassier G; Barillot C; Vérin M; Morandi X
    J Neurol; 2010 Mar; 257(3):375-82. PubMed ID: 19774437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of metabolic brain function by bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease.
    Wang J; Ma Y; Huang Z; Sun B; Guan Y; Zuo C
    J Neurol; 2010 Jan; 257(1):72-8. PubMed ID: 19662326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.